231 related articles for article (PubMed ID: 15886994)
1. Stereological studies of capillary length density in the frontal cortex of schizophrenics.
Kreczmanski P; Schmidt-Kastner R; Heinsen H; Steinbusch HW; Hof PR; Schmitz C
Acta Neuropathol; 2005 May; 109(5):510-8. PubMed ID: 15886994
[TBL] [Abstract][Full Text] [Related]
2. Evidence of altered calmodulin immunoreactivity in areas 9 and 32 of schizophrenic prefrontal cortex.
Broadbelt K; Jones LB
J Psychiatr Res; 2008 Jul; 42(8):612-21. PubMed ID: 18289558
[TBL] [Abstract][Full Text] [Related]
3. Deficit of pericapillary oligodendrocytes in the prefrontal cortex in schizophrenia.
Vostrikov V; Orlovskaya D; Uranova N
World J Biol Psychiatry; 2008; 9(1):34-42. PubMed ID: 17853252
[TBL] [Abstract][Full Text] [Related]
4. Cortical intercorrelations of frontal area volumes in schizophrenia.
Mitelman SA; Buchsbaum MS; Brickman AM; Shihabuddin L
Neuroimage; 2005 Oct; 27(4):753-70. PubMed ID: 15990338
[TBL] [Abstract][Full Text] [Related]
5. Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis.
Suzuki M; Zhou SY; Takahashi T; Hagino H; Kawasaki Y; Niu L; Matsui M; Seto H; Kurachi M
Brain; 2005 Sep; 128(Pt 9):2109-22. PubMed ID: 15930048
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefrontal cortex in schizophrenia and in unipolar depression.
Bertram I; Bernstein HG; Lendeckel U; Bukowska A; Dobrowolny H; Keilhoff G; Kanakis D; Mawrin C; Bielau H; Falkai P; Bogerts B
Ann N Y Acad Sci; 2007 Jan; 1096():147-56. PubMed ID: 17405926
[TBL] [Abstract][Full Text] [Related]
7. Neurons expressing calcium-binding proteins in the prefrontal cortex in schizophrenia.
Tooney PA; Chahl LA
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):273-8. PubMed ID: 14751422
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.
Gurevich EV; Joyce JN
Biol Psychiatry; 1997 Oct; 42(7):529-45. PubMed ID: 9376449
[TBL] [Abstract][Full Text] [Related]
9. No differences in calcium-binding protein immunoreactivity in the posterior cingulate and visual cortex: schizophrenia and controls.
Wheeler DG; Dixon G; Harper CG
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):630-9. PubMed ID: 16503370
[TBL] [Abstract][Full Text] [Related]
10. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method.
Selemon LD; Rajkowska G; Goldman-Rakic PS
J Comp Neurol; 1998 Mar; 392(3):402-12. PubMed ID: 9511926
[TBL] [Abstract][Full Text] [Related]
11. Hypothesis: minimal changes in neural transmission in schizophrenia: decreased glutamatergic and GABAergic functions in the prefrontal cortex.
Ohnuma T; Suzuki T; Arai H
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):889-94. PubMed ID: 15949884
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of MAP2 immunostaining in areas 9 and 17 in schizophrenia and Huntington chorea.
Somenarain L; Jones LB
J Psychiatr Res; 2010 Aug; 44(11):694-9. PubMed ID: 20092829
[TBL] [Abstract][Full Text] [Related]
13. Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics.
Radewicz K; Garey LJ; Gentleman SM; Reynolds R
J Neuropathol Exp Neurol; 2000 Feb; 59(2):137-50. PubMed ID: 10749103
[TBL] [Abstract][Full Text] [Related]
14. Increased prefrontal gyrification in a large high-risk cohort characterizes those who develop schizophrenia and reflects abnormal prefrontal development.
Harris JM; Moorhead TW; Miller P; McIntosh AM; Bonnici HM; Owens DG; Johnstone EC; Lawrie SM
Biol Psychiatry; 2007 Oct; 62(7):722-9. PubMed ID: 17509536
[TBL] [Abstract][Full Text] [Related]
15. Brain-derived neurotrophic factor polymorphisms and frontal cortex morphology in schizophrenia.
Varnäs K; Lawyer G; Jönsson EG; Kulle B; Nesvåg R; Hall H; Terenius L; Agartz I
Psychiatr Genet; 2008 Aug; 18(4):177-83. PubMed ID: 18628679
[TBL] [Abstract][Full Text] [Related]
16. Regional specificity of chandelier neuron axon terminal alterations in schizophrenia.
Konopaske GT; Sweet RA; Wu Q; Sampson A; Lewis DA
Neuroscience; 2006; 138(1):189-96. PubMed ID: 16337746
[TBL] [Abstract][Full Text] [Related]
17. Microvascular changes in late-life schizophrenia and mood disorders: stereological assessment of capillary diameters in anterior cingulate cortex.
Sinka L; Kovari E; Santos M; Herrmann FR; Gold G; Hof PR; Bouras C; Giannakopoulos P
Neuropathol Appl Neurobiol; 2012 Dec; 38(7):696-709. PubMed ID: 22360590
[TBL] [Abstract][Full Text] [Related]
18. Distribution of neuropeptide Y interneurons in the dorsal prefrontal cortex of schizophrenia.
Ikeda K; Ikeda K; Iritani S; Ueno H; Niizato K
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):379-83. PubMed ID: 14751436
[TBL] [Abstract][Full Text] [Related]
19. Brain volume and dysexecutive behavior in schizophrenia.
Kawada R; Yoshizumi M; Hirao K; Fujiwara H; Miyata J; Shimizu M; Namiki C; Sawamoto N; Fukuyama H; Hayashi T; Murai T
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1255-60. PubMed ID: 19625009
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Dulay JR; Weis S
Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
